Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.

Volume 2 (2005), Issue 1 (January)

1. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient.
   Respiration, 71(6): 646-9. [Abstract] [Full-text]
2. BALF nitrite as an indicator of inflammation in children with cystic fibrosis.
   Respiration, 71(6): 625-9. [Abstract] [Full-text]
3. Caesarean section in a patient with cystic fibrosis.
   Int J Obstet Anesth, 14(1): 70-3. [Abstract] [Full-text]
4. Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis.
   Pediatr Pulmonol, 39(2): 156-61. [Abstract] [Full-text]
5. Immunoglobulin and IgG subclass levels in a regional pediatric cystic fibrosis clinic.
   Pediatr Pulmonol, 39(2): 135-40. [Abstract] [Full-text]
6. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis.
   Proc Natl Acad Sci U S A, 102(1): 186-91. [Abstract] [Full-text]
7. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.
   Pediatr Pulmonol, 39(2): 103-7. [Abstract] [Full-text]
8. Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureus.
   J Clin Microbiol, 43(1): 502-5. [Abstract] [Full-text]
9. Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study.
   Eur Respir J, 25(1): 62-8. [Abstract] [Full-text]
10. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.
    Eur Respir J, 25(1): 54-61. [Abstract] [Full-text]
11. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population.
    Ann Hum Genet, 69: 15-24. [Abstract] [Full-text]
12. One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.
    Am J Respir Crit Care Med, 171(2): 158-64. [Abstract] [Full-text]
13. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    J Biol Chem, 280(2): 1346-53. [Abstract] [Full-text]
14. Rational approach to genetic testing of cystic fibrosis (CF) in infertile men.
    Andrologia, 37(1): 1-9. [Abstract] [Full-text]
15. A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis.
    Chest, 127(1): 308-17. [Abstract] [Full-text]
16. Advenella incenata gen. nov., sp. nov., a novel member of the Alcaligenaceae, isolated from various clinical samples.
    Int J Syst Evol Microbiol, 55: 251-6. [Abstract] [Full-text]
17. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship.
    Clin Exp Immunol, 139(2): 306-13. [Abstract] [Full-text]
18. Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis.
    Eur J Clin Microbiol Infect Dis, 24(1): 54-7. [Abstract] [Full-text]
19. Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil.
    Braz J Med Biol Res, 38(1): 11-5. [Abstract] [Full-text]
20. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Am J Respir Crit Care Med, 171(3): 257-60. [Abstract] [Full-text]
21. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.
    Am J Respir Crit Care Med, 171(3): 249-56. [Abstract] [Full-text]
22. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
23. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    J Antimicrob Chemother, 55(2): 269-71. [Abstract] [Full-text]
24. Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation.
    Thorax, 60(2): 159-63. [Abstract] [Full-text]
25. Energetic cost of physical activity in cystic fibrosis children during Pseudomonas aeruginosa pulmonary exacerbation.
    Clin Nutr, 24(1): 88-96. [Abstract] [Full-text]
26. Association of body composition and lung function in children with cystic fibrosis.
    Pediatr Pulmonol, 39(3): 276-80. [Abstract] [Full-text]
27. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Pediatr Pulmonol, 39(3): 224-32. [Abstract] [Full-text]
28. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
    Pediatr Pulmonol, 39(3): 209-18. [Abstract] [Full-text]

© 2004-2008 Cystic Fibrosis Research Today. All Rights Reserved.